Clinical trial / 2008
Application of a 1% CoQ10 cream for five months reduced dermatologist-observed wrinkle score grade.
Researchers examined the mechanisms of coenzyme Q10 (CoQ10) on UVB-induced wrinkle formation in vitro and in a clinical trial. In vitro, CoQ10 decreased UVB-induced IL-6 production in normal human keratinocytes and significantly decreased MMP-1 production in fibroblasts over 24 hours. In the clinical trial, the use of a 1% CoQ10 cream for five months reduced wrinkle score grade as observed by a dermatologist.
- Study type
- Clinical trial and in vitro study
- Who was studied
- Human participants (sample size not stated)
- What was measured
- Wrinkle score grade observed by a dermatologist; in vitro IL-6 and MMP-1 levels
THE PAPER
Mechanisms of inhibitory effects of CoQ10 on UVB-induced wrinkle formation in vitro and in vivo.
Inui M, Ooe M, Fujii K, Matsunaka H, Yoshida M, Ichihashi M. Biofactors, 2008.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.